HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 600-608

  Omelyanenko, Vladimir ^a   Gentry, Christine ^a   Kopečková, Pavla ^a   Kopeček, Jindřich ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; DOXORUBICIN; IMMUNOGLOBULIN G1; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER; PHOTOSENSITIZING AGENT; RHODAMINE; TALAPORFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG BINDING; DRUG CYTOTOXICITY; DRUG TARGETING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HYBRIDOMA; INTERNALIZATION; INTRACELLULAR TRANSPORT; LYSOSOME; MOUSE; NONHUMAN; OVARY CARCINOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BIOLOGICAL TRANSPORT; CELL COMPARTMENTATION; CELL SURVIVAL; CELLS, CULTURED; DOXORUBICIN; ENDOCYTOSIS; FEMALE; HUMANS; IMMUNOTOXINS; LYSOSOMES; MESOPORPHYRINS; METHACRYLATES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; OVARIAN NEOPLASMS; PHOTOSENSITIZING AGENTS; TUMOR CELLS, CULTURED; VEHICLES;

EID: 0032498552     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<600::AID-IJC18>3.0.CO;2-C     Document Type: Article

References (24)

1. BOERMAN, O., MASSUGER, L., MAKKINK, K., THOMAS, C., KENEMANS, P. and POELS, L., Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies. Anticancer Res., 10, 1289-1296 (1990).
2. BUIST, M.R., KENEMANS, P., MOLTHOFF, C.F.M., ROOS, J.C., DEN HOLLANDER, W., BRINKHUIS, M. and BAAK, P.A., Tumor uptake of intravenously administered radiolabeled antibody in ovarian carcinoma patients in relation to antigen expression and other tumor characteristics. Int. J. Cancer (Pred. Oncol.), 64, 92-98 (1995a).
3. BUIST, M.R., MOLTHOFF, C.F.M., KENEMANS, P. and MEIJER, C.J.L.M., Distribution of OV-TL3 and Mov18 in normal and malignant ovarian tissue. J. clin. Pathol. 48, 631-636 (1995b).
4. CAMPBELL, I.G., FREEMOST, P.S., FOULKES, W. and TROWSDALE, J., An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res., 52, 5416-5420 (1992).
5. CASALINI, P., MEZZANZANICA, D., CANEVAKI, S., TORRE, G.D., MIOTTI, S., COLNAGHI, M.I. and MATZKU, S., Use of combination of monoclonal antibodies directed against three distinct epitopes of a tumor-associated antigen: analysis of cell binding and internalization. Int. J. Cancer, 48, 284-290 (1991).
6. CASSIDY, J., VASEY, P., KAYE, S.B. and DUNCAN, R., A phase 1 clinical trial of PK1: a novel drug targeting system in human cancers. In: Proceedings 2nd Int. Symp. Polymer Therapeutics, Kumamoto, Japan (1997).
7. CHANG, K., PAI, L.H., BATRA, J.K., PASTAN, I. and WILLINGHAM, M.C., Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium. Cancer Res., 52, 181-186 (1992).
8. DE LANGE, J.H.M., SCHIPPER, N.W., SCHUURHUIS, G.J., TEN KATE, T.K., VAN HENNINGEN, T.H.M., PINEDO, H.M., LANKELMA, J. and BAAK, J.P.A., Quantification by laser scan microscopy of intracellular doxorubicin distribution. Cytometry, 13, 571-576 (1992).
9. FOLKMAN, J., How is blood vessel growth regulated in normal and neoplastic tissue? GHA Clowes memorial award lecture. Cancer Res., 46, 467-473 (1986).
10. HAMILTON, T.C., YOUNG, R.C., MCKOY, W.M., GROTZINGER, K.R., GREEN, J., CHU. E.W., WHANG-PENG, J., ROGAN, A.M., GREEN, W.R. and OXOLS, R.F., Characterization of a human ovarian carcinoma cell line (NIH: OVCAR-3) with androgen and estrogen receptors. Cancer Res., 43, 5379-5389 (1983).
11. HANSEN, M.B., NIELSEN, S.E. and BERG, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119, 203-210 (1989).
12. JUWEID, M., NEUMANN, R., PAIK, C., PEREZ-BACETE, M.J., SATO, J., VAN OSDOL, W. and WEINSTEIN, J.N., Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res., 52, 5144-5153 (1992).
13. KOPEČEK, J., REJMANOVÁ, P., STROHALM, J., ULBRICH, K., ŘÍHOVÁ, B., CHYTRÝ, V., LLOYD, J.B. and DUNCAN, R., Synthetic polymeric drugs. U.S. Pat. 5,037,883 (Aug. 6, 1991).
14. KRINICK, N., SUN, Y., JOYNEK, D., SPIKES, J.D., STRAIGHT, R.C. and KOPECFK, J., A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light. J. Biomat. Sci. Polym. Ed., 5, 303-324 (1994).
15. MAEDA, H., SEYMOUR, L.M. and MIYAMOTO, Y., Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjugate Chem., 3, 351-362 (1992).
16. OMELYANENKO, V., KOPEČKOVÁ, P., GENTRY, C. and KOPEĚEK, J.,Targetable HPMA copolymer-adriamycin conjugates. Recognition. internalization, and subcelluiar fate. J. Controlled Release, (1998) (In press).
17. OMELYANENKO, V., KOPEČKOVÁ, P., GENTRY, C., SHIAH, J.-G. and KOPEČEK, J., HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. Influence of the methods of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. J. Drug Targeting, 3, 357-373 (1996).
18. OPRHSKO, L.K., CHANG, C.-R. WILL, B.H., BURKE, P.M., GILL, G.N. and WILEY, S.H., Endocytosis and lysosomal targeting of epidermal growth factor receptors are mediated by distinct sequences independent of the tyrosine kinase domain. J. biol Chem., 270, 4325-4333 (1995).
19. PETERSON, C.M., Lu, J.M., SUN, Y. PETERSON, C.A., SHIAH, J.-G., STRAIGHT, R.C. and KOPEČEK, J., Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl)methacrylamitle copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Cancer Res., 56, 3980-3985 (1996).
20. POELS, L.G., PETERS, D., VAN MEGEN, Y. Voous, P.G., VEHEWEN, R.H.M., WILLEMEN, A., VAN NIEKERK, C.C., JAP, P.H., MUNGYER, G. and KENEMANS, P., Monoclonal antibody against human ovarian tumor-associated antigens. J. nat. Cancer Inst., 76, 781-787 (1986).
21. PUTNAM, D. and KOPEČEK, J., Polymer conjugates with anticancer activity. Adv. Polym. Sci., 122, 55-123 (1995).
22. REJMANOVÁ, P., POHL, J., BAUDYŠ, M., KOSTKA, V. and KOPEČEK, J., Polymers containing enzymatically degradable bonds. 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B. Makromol. Chem., 184, 2009-2020 (1983).
23. ŘÍHOVÁ, B., KOPEČKOV́A, P., STROHALM, J., ROSSMANN, P., VĚTVIČKA, V. and KOPEČEK, J., Antibody-directed affinity therapy applied to the immune system. In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymer and targeting antibody. Clin. Immunol. Immunopathol, 46, 100-114 (1988).
24. YUAN, F., DELLIAN, M., FUKUMURA, D., LEUNIG, M., BERK, D.A.,TORCHILIN, V.P, and JAIN, R.K., Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res., 55, 3752-3756 (1995).